ITEM 5 — OTHER INFORMATION
−Removed: During the three months ended March 31, 2024, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted , terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).
+Added: During the three months ended June 30, 2024, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934) adopted , terminated or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).
CNDT Q2 2024 Form 10-Q
4 unchanged sentences
8-K 2.1 9/19/2023
+Added: 2.2 First Amendment to Custodial Transfer and Purchase Agreement, between Conduent Business Services, LLC and HealthEquity, Inc., dated as of March 7, 2024.
3.1 Restated Certificate of Incorporation of Registrant filed with the Department of the State of New York on December 31, 2016.
2 unchanged sentences
10-Q 3.2 11/1/2023
−Removed: 10.1** Form of Director and Officer Indemnification Agreement.
−Removed: 10-Q 10.1 11/1/2023
−Removed: 10.6(a)(i)** Form of Restricted Stock Unit Award Agreement 2024 under the 2021 PIP
−Removed: 10.6(a)(ii)** Form of Performance Stock Unit Award Agreement 2024 (Adjusted Revenue Growth) under the 2021 PIP.
−Removed: 10.6(a)(iii)** Form of Performance Stock Unit Award Agreement 2024 (rTSR) under the 2021 PIP.
+Added: 10.1 Purchase Agreement dated June 8, 2024 among the Company and the Icahn Parties .
+Added: 8-K 10.1 6/10/2024
Certification of CEO pursuant to Rule 13a-14(a) or Rule 15d-14(a).
2 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101 The following materials from the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 formatted in Inline XBRL:
+Added: 101 The following materials from the Registrant's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 formatted in Inline XBRL:
(i) Consolidated Statements of Income, (ii) Consolidated Statements of Comprehensive Income, (iii) Consolidated Balance Sheets, (iv) Consolidated Statements of Cash Flows, (v) Consolidated Statements of Shareholders' Equity and (vi) Notes to Consolidated Financial Statements.
8 unchanged sentences
(Principal Financial Officer)
+Added: August 7, 2024
CNDT Q2 2024 Form 10-Q
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.